Literature DB >> 24939559

Future directions for the investigation of intranasal oxytocin and pain: Comment on: Oxytocin nasal spray in fibromyalgic patients (Rheumatol Int. E-pub ahead of print. doi: 10.1007/s00296-014-2953-y).

Joshua A Rash1, Tavis S Campbell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24939559     DOI： 10.1007/s00296-014-3070-7

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  8 in total

Review 1.  A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research.

Authors:  Elayne MacDonald; Mark R Dadds; John L Brennan; Katrina Williams; Florence Levy; Avril J Cauchi
Journal:  Psychoneuroendocrinology       Date:  2011-03-23       Impact factor: 4.905

2.  G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences.

Authors:  Franz Faul; Edgar Erdfelder; Albert-Georg Lang; Axel Buchner
Journal:  Behav Res Methods       Date:  2007-05

3.  Effect of oxytocin on placebo analgesia: a randomized study.

Authors:  Simon Kessner; Christian Sprenger; Nathalie Wrobel; Katja Wiech; Ulrike Bingel
Journal:  JAMA       Date:  2013-10-23       Impact factor: 56.272

4.  Oxytocin nasal spray in fibromyalgic patients.

Authors:  S Mameli; G M Pisanu; S Sardo; A Marchi; A Pili; M Carboni; L Minerba; G Trincas; M G Carta; M R Melis; R Agabio
Journal:  Rheumatol Int       Date:  2014-02-08       Impact factor: 2.631

Review 5.  Oxytocin and pain: a systematic review and synthesis of findings.

Authors:  Joshua A Rash; Aldo Aguirre-Camacho; Tavis S Campbell
Journal:  Clin J Pain       Date:  2014-05       Impact factor: 3.442

6.  Intranasal oxytocin attenuates the cortisol response to physical stress: a dose-response study.

Authors:  Christopher Cardoso; Mark A Ellenbogen; Mark Anthony Orlando; Simon L Bacon; Ridha Joober
Journal:  Psychoneuroendocrinology       Date:  2012-08-11       Impact factor: 4.905

7.  The effect of intranasal oxytocin administration on acute cold pressor pain: a placebo-controlled, double-blind, within-participants crossover investigation.

Authors:  Joshua A Rash; Tavis S Campbell
Journal:  Psychosom Med       Date:  2014 Jul-Aug       Impact factor: 4.312

8.  Elevated Salivary Levels of Oxytocin Persist More than 7 h after Intranasal Administration.

Authors:  Marinus H van Ijzendoorn; Ritu Bhandari; Rixt van der Veen; Karen M Grewen; Marian J Bakermans-Kranenburg
Journal:  Front Neurosci       Date:  2012-12-07       Impact factor: 4.677
  8 in total
  5 in total

1.  The lack of efficacy of oxytocin and NSAIDs.

Authors:  Roberta Agabio; Sergio Mameli; Maria Rosaria Melis
Journal:  Rheumatol Int       Date:  2015-01-15       Impact factor: 2.631

2.  Oxytocin nasal spray in fibromyalgic patients: additional information : reply to the comment to the editor entitled "future directions for the investigation of intranasal oxytocin and pain".

Authors:  Roberta Agabio; Sergio Mameli; Salvatore Sardo; Luigi Minerba; Maria Rosaria Melis
Journal:  Rheumatol Int       Date:  2014-07-29       Impact factor: 2.631

3.  Intranasal oxytocin and NSAIDs : Comment on: Oxytocin nasal spray in fibromyalgic patients (Rheumatol Int. 2014 Aug;34(8):1047-52.).

Authors:  Kenneth K Kwong; Suk-tak Chan
Journal:  Rheumatol Int       Date:  2014-10-30       Impact factor: 2.631

4.  Protocol for a placebo-controlled, within-participants crossover trial evaluating the efficacy of intranasal oxytocin to improve pain and function among women with chronic pelvic musculoskeletal pain.

Authors:  Joshua A Rash; Kirsti Toivonen; Magali Robert; Maryam Nasr-Esfahani; John F Jarrell; Tavis S Campbell
Journal:  BMJ Open       Date:  2017-04-16       Impact factor: 2.692

Review 5.  Oxytocin and cancer: An emerging link.

Authors:  Ben Lerman; Trisheena Harricharran; Olorunseun O Ogunwobi
Journal:  World J Clin Oncol       Date:  2018-09-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.